The Quantulus GCT 6220 is a liquid scintillation counter for ultra low-level sensitivity, in a lighter benchtop footprint to fit any lab. It has extremely high sensitivity and unmatched detection of low level Alpha and Beta radioactivity.
The Quantulus GCT 6220 liquid scintillation counter is a fully loaded benchtop instrument with unsurpassed performance for measuring man made, cosmic and other natural radionuclides. Patented GCT technology combined with BGO guard background reduction accurately measures to near-background levels. Proprietary Dual PSA Discriminator and PSA Histogram improves accuracy for mixed and unknown samples.
Exclusive Standard Features
Patented Bismuth Germanium Oxide (BGO) and Guard Compensation Technology (GCT) enhances discrimination against background yielding the highest E2/B values available in a multipurpose liquid scintillation counting system
TR-LSC (Time-resolved Liquid Scintillation Counting) for high sensitivity, low background liquid scintillation counting
QuantaSmart™ Software a robust multitasking, easy networking environment with unlimited assays in a secure multiuser environment
Alpha Beta Separation uses Dual PSA Discriminator and PSA Histogram to improve accuracy for mixed and unknown samples
SpectraWorks 2 spectral analysis package that determines optimal counting regions, and calculates figure of merit automatically
Enhanced IPA (Instrument Performance Assessment) monitors performance metrics for the life of the instrument
Replay reanalyzes sample counts without recounting samples
Dynamic color correction ensures accuracy of tracking lower energy sample spectra over a wide quench range
Auxiliary Spectrum Memory stores rejected events for future analysis
Bi-directional sample conveyer with a capacity of up to 408 (20mL vials) or 720 (4 or 7 mL vials)
Varisette™ sample cassette for intermixing vial sizes without special adapters
Operational-status LED indicator for clear assay status updates at a glance
Additional Standard Features
Luminescence Detection flags percent luminescence to alert user of possible sample problems
Luminescence Correction adjusts for chemiluminescence interference
Direct DPM determines single-label DPM in any cocktail without the use of quench standards
Temperature Control maintains optimum conditions for a variety of samples
60 Quick Count protocol flags with the flexibility to define unlimited assays
Fold-away ergonomic arm adaptable to enter data either sitting or standing
Built in Computer with Windows 10 Operating System
Figure of Merit (E2/B), Normal Count Mode: 3H (0-18.6 keV): 400 14C (0-156 keV): 1,0000
Figure of Merit (E2/B), Super Low Level Count Mode (ULLCM): 3H (0-18.6 keV): 800 14C (0-156 keV): 6,000
Observed 3H Performance with 10 mL H2O in 10 mL Ultima Gold LLT and Plastic Vials with GCT high E2V2/B > 131,000 or more
Observed 14C Performance for 11 mL Bioethanol Samples in 9 mL Ultima Gold F in Plastic Vials with GCT high: E2V2/B > 1,030,000 or more
Note: The efficiencies, backgrounds, and E2 /B values for the Normal Count Mode were determined using PerkinElmer sealed large vial glass standards set P.N. 6008500 verified with NIST standard activity. Super Low Level Count Mode Values are determined using low level sealed large glass standards P.N. 6018914 verified with NIST standard activity. No maximum is specified for background.
The analysis of drinking water is a continued focus of many laboratories globally. While the determination of the activity of Tritium (3H), Radon-222 (222Rn) and gross a/ß-activity has historically been routine in many laboratories, the European Council Directive 2013/51/Euratom contained updated recommendations for sampling rate, detection limits, and other parameters which have forced many labs to upgrade instrumentation and adjust their previous methods. Learn how the Quantulus™ GCT 6220 provides the sensitivity needed to meet today’s most stringent compliance requirements.
Radiometric detection (RAD) is one of the most proven techniques for molecular quantitation around – and it’s still indispensable for key applications. Here’s the state of the industry, and where it’s headed.
